1 / 15

Ingenza NewProt Kick-off meeting 25 Jan 2012 Nijmegen

Ingenza NewProt Kick-off meeting 25 Jan 2012 Nijmegen. Ian Archer Ingenza Ltd Roslin, Edinburgh UK. Ingenza – what we do. Synthetic Biology Technologies Biocatalysis /Bioprocess development Protein expression/enzyme evolution Screening for improved biocatalysts/processes

Télécharger la présentation

Ingenza NewProt Kick-off meeting 25 Jan 2012 Nijmegen

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. IngenzaNewProt Kick-off meeting25 Jan 2012Nijmegen Ian Archer Ingenza Ltd Roslin, Edinburgh UK

  2. Ingenza – what we do • Synthetic Biology Technologies • Biocatalysis/Bioprocess development • Protein expression/enzyme evolution • Screening for improved biocatalysts/processes • Novel enabling technologies e.g. gENABLE • Business areas • Fine chemicals • Biologics • Biofuels • Synthetic biology / petrochemical replacement • Biopolymers • Diagnostics

  3. Initial company focus: biosynthesis of chiral compounds Engineered microbial biocatalysts • Platform technologies • e.g. oxidase and aminotransferase biocatalysts • Unnatural amino acids and chiral amines • Large scale processes, compounds >99% e.e. • Highly expressed enzymes • High cell density fermentation • Efficient process chemistry • Enzymes adapted by mutation/screening • New specificities • Improved reaction properties • Process optimisation • Stabilised biocatalysts • Diverse enzyme production systems • Biocatalyst formulation • Statistical design of experiments

  4. Expression systems Continuing to expand and diversify • Bacteria: E.coli • Large range of host/vector systems • Inducible, constitutive, synthetic • C.glutamicum / C.acetobutylicum • Customising host/vector systems • Yeast: Saccharomyces, Pichia • Range of host/vector systems • Cytosolic/Partitioned/Secretion • Integration vectors/copy number control • Fusions to identify novel regulatory regions • Fungi: A.niger, A. terreus • Customising host/vector systems • Inducible/Constitutive • Insect cell/mammalian • Production of biologics

  5. Screening to adapt enzyme specificity or improve performance Colorimetric, qualitative solid phase/quantitative liquid phase oxidase • Adapted to solid phase • Proprietary • Very high throughput • Millions of variants HRP Substrate • Micro-titre plate assay • Straight forward visual read-out • Kinetic characterisation of variants

  6. Colorimetric screening Improved enzyme activity or protein expression • The screen detects • improved activity AND/OR • improved expression Can be used in conjunction with: • Gene synthesis, now standard in molecular biology • Gene assembly methods to rapidly generate expression libraries • Assists selection of the optimal expression system • Assists selection of the optimal gene sequence • Delivers the highest quantity and quality of expressed protein • Screening libraries is a powerful tool

  7. Enzyme adaptation:Increased enzyme thermostability/robustness • Three rounds of laboratory evolution • Stable in process • Resistant to chemical denaturation • Resistant to physical denaturation • Not stable in process • Susceptible to chemical denaturation • Susceptible to physical denaturation

  8. Screening for efficient protein production Applied to biologic target to identify top 50 from 50,000 • Library built (50,000 variants) • Oversampled (500,000 clones) • Hits identified visually • 500 initial positive hits • - re-assayed • PCR screen to confirm • liquid phase assay to quantify • 50 Best hits identified • sub-cloned • SDS-PAGE/Western assay • Provided to customer Over-expressing clone

  9. Synthetic biology Replacement of petrochemical and other starting materials • Partnership with Lucite International • Global producer of industrial polymers • Engaged in multi year contract • Microbial strain construction • Synthetic Biology – pathway engineering • Screening: Crossfeeding, Zone clearing, pH based • Fermentation development • Management of strategic academic collaboration • Additional contracts now initiated • Biomass as replacement for petrochemical feedstock • Fermentation route to natural food additive • Multi-target • Synthetic Biology to develop efficient production microbes • Bacteria/Yeast/Fungi • Proprietary genetic platforms accelerate strain improvement

  10. gENABLE – Genome segment assembly • Co-developed by Ingenza and Scottish Government • Ingenza applying broadly in Industrial Biotechnology • Assembly of genes, variants, reporters, markers, regulatory elements • High-throughput, one-pot combinatorial assemblies • Combines Bioinformatics, Microfluidics, Novel bio-reactions • Accelerates: • Optimisation of gene expression • Pathway construction/engineering • Efficient synthesis of target products • Applicable in all areas of protein expression • Now central to all Ingenza enabling technologies and business areas • Synergistic with screening • Colorimetric, pH, crossfeeding, zone clearing, protein fusions

  11. gENABLE Why? Expressing proteins is easy - isn’t it? Welch. M. Journal of the Royal Society. Interface 11th March (2009)

  12. gENABLE Specific linker based genetic pathway construction Assemblies of up to 10 parts have been demonstrated

  13. gENABLE 5 part combinatorial assembly for co-ordinated enzyme expression Position A Position B Position C Position D Position E Gene 1 Gene 2 Gene 3 Pr. 1 Ter. Pr. 1 Ter. Pr. 1 Ter. 2 µ origin Gene 1 Gene 2 Gene 3 Marker Pr. 2 Ter. Pr. 2 Ter. Pr. 2 Ter. CEN4 origin Gene 1 Gene 2 Gene 3 Pr. 3 Ter. Pr. 3 Ter. Pr. 3 Ter. 2 origins of replication 3 variants 3 variants 3 variants 1 marker Vector backbones Assembly of 54 different genetic constructs in a single reaction Overcomes limits of empirical bioprocess optimisation Faster route to optimal bioprocess

  14. gENABLE Example of results • Combination of 5 independent DNA fragments • Assembly of synthetic enzyme pathway • Typically a problematic empirical process • Results in 95% success in correct pathway assembly (dark clones) > 95 % positive clones

  15. NewProt Workpackage 6 @ Ingenza Experimental validation • Tasks • Bioinformatics to identify aminotransferases (plus as many as possible of at least another 11 enzyme superfamilies) with diverse, novel activities towards commercially specific targets • Pathway engineering to incorporate activities into hosts • Develop screens to identify best production constructs • Screening of libraries to identify desired activities • Focus areas? • Enzyme promiscuity to identify novel activities • Use of bioinformatics to demystify expression / activity etc

More Related